U.S. Physical Therapy (USPH) Target Bumped at Jefferies

Jefferies analyst Brian Tanquilut bumped his price target on Buy-rated U.S. Physical Therapy (NYSE: USPH) from $34 to $38 saying 2014 should be a good year for acquisitions and organic growth.

Tanquilut said, "We have a positive bias on USPH given our belief that the company's outlook continues to improve as the stabilization of the broader economy and ongoing market share gains are driving positive organic revenue trends and margin improvements. With mgmt. focused on deploying capital to opportunistically pursue acquisition opportunities and bolster internal growth, we see USPH continuing to go higher from current levels."

The firm trims FY 2014 EPS from $1.66 to $1.57.

For an analyst ratings summary and ratings history on U.S. Physical Therapy click here. For more ratings news on U.S. Physical Therapy click here.

Shares of U.S. Physical Therapy closed at $33.09 yesterday.

You May Also Be Interested In